Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma

Published:2017-06 Issue:3 Volume:15 Page:403-410.e2
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

De Velasco Guillermo,Xie Wanling,Donskov Frede,Albiges Laurence,Beuselinck Benoit,Srinivas Sandy,Agarwal Neeraj,Lee Jae Lyun,Brugarolas James,Wood Lori A.,Rha Sun-young,Kollmannsberger Christian,North Scott,Kanesvaran Ravindran,Rini Brian I.,Broom Reuben,Yamamoto Haru,Kaymakcalan Marina D.,Heng Daniel Y.C.,Choueiri Toni K.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference26 articles.

1. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;N Engl J Med,2007

2. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

3. Treatment patterns in metastatic renal cell carcinoma: a retrospective review of medical records from US community oncology practices;Jonasch;Curr Med Res Opin,2014

4. Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206;Rini;J Clin Oncol,2008

5. Pazopanib versus sunitinib in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal cell carcinoma management: real-world practice and challenges at a national level;Future Oncology;2023-04

2. Clinical impact of early response to first‐line VEGFR‐TKI in patients with metastatic renal cell carcinoma on survival: A multi‐institutional retrospective study;Cancer Medicine;2022-10-06

3. Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma;Japanese Journal of Clinical Oncology;2021-08-04

4. Management of advanced kidney cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2021;Canadian Urological Association Journal;2021-03-10

5. Testosterone for Managing Treatment-related Fatigue in Patients With Metastatic Renal Cell Carcinoma;American Journal of Clinical Oncology;2021-01-27